Joel S. Marcus, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 30,500 shares at $34.93 ($1.1M) on 2021-03-02, disclosed to the SEC on 2021-03-04.
Open-market sale of $1.1M ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.93 | 15,250 | $533K | 50.0% |
| 2 | $34.93 | 15,250 | $533K | 50.0% |
| Total | $34.93 avg | 30,500 | $1.1M | 100% |
| Filing → |
| ARE | BUY | 2026-05-07 | $348K | — | Filing → |
| ARE | BUY | 2026-05-06 | $320K | — | Filing → |
| ARE | BUY | 2026-05-05 | $410K | — | Filing → |